nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A2—Cytarabine—lymphatic system cancer	0.182	0.206	CbGbCtD
Prazosin—SLC22A1—Cytarabine—lymphatic system cancer	0.158	0.179	CbGbCtD
Prazosin—SLC22A3—Vincristine—lymphatic system cancer	0.146	0.165	CbGbCtD
Prazosin—ABCG2—Teniposide—lymphatic system cancer	0.133	0.15	CbGbCtD
Prazosin—ABCG2—Mitoxantrone—lymphatic system cancer	0.0928	0.105	CbGbCtD
Prazosin—ABCG2—Vincristine—lymphatic system cancer	0.0638	0.0721	CbGbCtD
Prazosin—ABCG2—Methotrexate—lymphatic system cancer	0.0386	0.0437	CbGbCtD
Prazosin—ABCB1—Mitoxantrone—lymphatic system cancer	0.0334	0.0378	CbGbCtD
Prazosin—ABCB1—Vincristine—lymphatic system cancer	0.023	0.026	CbGbCtD
Prazosin—ABCB1—Methotrexate—lymphatic system cancer	0.0139	0.0157	CbGbCtD
Prazosin—Retinal disorder—Methotrexate—lymphatic system cancer	0.00206	0.0179	CcSEcCtD
Prazosin—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00179	0.0156	CcSEcCtD
Prazosin—Alopecia—Mechlorethamine—lymphatic system cancer	0.0017	0.0148	CcSEcCtD
Prazosin—Urinary incontinence—Carmustine—lymphatic system cancer	0.00153	0.0134	CcSEcCtD
Prazosin—Sweating increased—Fludarabine—lymphatic system cancer	0.00152	0.0132	CcSEcCtD
Prazosin—Angina pectoris—Fludarabine—lymphatic system cancer	0.00152	0.0132	CcSEcCtD
Prazosin—Vertigo—Mechlorethamine—lymphatic system cancer	0.0015	0.0131	CcSEcCtD
Prazosin—Gynaecomastia—Carmustine—lymphatic system cancer	0.00142	0.0124	CcSEcCtD
Prazosin—Flushing—Teniposide—lymphatic system cancer	0.00131	0.0115	CcSEcCtD
Prazosin—Epistaxis—Fludarabine—lymphatic system cancer	0.00131	0.0114	CcSEcCtD
Prazosin—Eye pain—Carmustine—lymphatic system cancer	0.00128	0.0111	CcSEcCtD
Prazosin—Alopecia—Teniposide—lymphatic system cancer	0.00125	0.0109	CcSEcCtD
Prazosin—Alopecia—Fludarabine—lymphatic system cancer	0.0011	0.00959	CcSEcCtD
Prazosin—Oedema—Teniposide—lymphatic system cancer	0.00101	0.00877	CcSEcCtD
Prazosin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00101	0.00877	CcSEcCtD
Prazosin—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00101	0.00877	CcSEcCtD
Prazosin—Tachycardia—Teniposide—lymphatic system cancer	0.000982	0.00856	CcSEcCtD
Prazosin—Malaise—Fludarabine—lymphatic system cancer	0.000978	0.00852	CcSEcCtD
Prazosin—Hyperhidrosis—Teniposide—lymphatic system cancer	0.000973	0.00848	CcSEcCtD
Prazosin—Pruritus—Mechlorethamine—lymphatic system cancer	0.000966	0.00842	CcSEcCtD
Prazosin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000934	0.00814	CcSEcCtD
Prazosin—Arthralgia—Fludarabine—lymphatic system cancer	0.000923	0.00804	CcSEcCtD
Prazosin—Discomfort—Fludarabine—lymphatic system cancer	0.000912	0.00795	CcSEcCtD
Prazosin—Sweating increased—Mitoxantrone—lymphatic system cancer	0.000902	0.00786	CcSEcCtD
Prazosin—Dyspnoea—Teniposide—lymphatic system cancer	0.000897	0.00782	CcSEcCtD
Prazosin—Oedema—Fludarabine—lymphatic system cancer	0.000885	0.00771	CcSEcCtD
Prazosin—Erectile dysfunction—Vincristine—lymphatic system cancer	0.000875	0.00763	CcSEcCtD
Prazosin—Vomiting—Mechlorethamine—lymphatic system cancer	0.000868	0.00757	CcSEcCtD
Prazosin—Rash—Mechlorethamine—lymphatic system cancer	0.000861	0.0075	CcSEcCtD
Prazosin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00086	0.0075	CcSEcCtD
Prazosin—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000855	0.00745	CcSEcCtD
Prazosin—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000852	0.00743	CcSEcCtD
Prazosin—Flushing—Bleomycin—lymphatic system cancer	0.000847	0.00739	CcSEcCtD
Prazosin—Feeling abnormal—Teniposide—lymphatic system cancer	0.000829	0.00723	CcSEcCtD
Prazosin—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000825	0.00719	CcSEcCtD
Prazosin—Nausea—Mechlorethamine—lymphatic system cancer	0.000811	0.00707	CcSEcCtD
Prazosin—Alopecia—Bleomycin—lymphatic system cancer	0.000807	0.00703	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000806	0.00703	CcSEcCtD
Prazosin—Urticaria—Teniposide—lymphatic system cancer	0.0008	0.00697	CcSEcCtD
Prazosin—Body temperature increased—Teniposide—lymphatic system cancer	0.000796	0.00694	CcSEcCtD
Prazosin—Paraesthesia—Fludarabine—lymphatic system cancer	0.000794	0.00692	CcSEcCtD
Prazosin—Hallucination—Carmustine—lymphatic system cancer	0.000793	0.00691	CcSEcCtD
Prazosin—Dyspnoea—Fludarabine—lymphatic system cancer	0.000789	0.00687	CcSEcCtD
Prazosin—Fatigue—Fludarabine—lymphatic system cancer	0.000763	0.00665	CcSEcCtD
Prazosin—Hallucination—Vincristine—lymphatic system cancer	0.000757	0.0066	CcSEcCtD
Prazosin—Pain—Fludarabine—lymphatic system cancer	0.000757	0.00659	CcSEcCtD
Prazosin—Constipation—Fludarabine—lymphatic system cancer	0.000757	0.00659	CcSEcCtD
Prazosin—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000754	0.00657	CcSEcCtD
Prazosin—Vasculitis—Methotrexate—lymphatic system cancer	0.000753	0.00656	CcSEcCtD
Prazosin—Hypersensitivity—Teniposide—lymphatic system cancer	0.000742	0.00646	CcSEcCtD
Prazosin—Flushing—Carmustine—lymphatic system cancer	0.00074	0.00645	CcSEcCtD
Prazosin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000737	0.00643	CcSEcCtD
Prazosin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000729	0.00635	CcSEcCtD
Prazosin—Asthenia—Teniposide—lymphatic system cancer	0.000722	0.00629	CcSEcCtD
Prazosin—Malaise—Bleomycin—lymphatic system cancer	0.000717	0.00625	CcSEcCtD
Prazosin—Pruritus—Teniposide—lymphatic system cancer	0.000712	0.00621	CcSEcCtD
Prazosin—Alopecia—Carmustine—lymphatic system cancer	0.000704	0.00614	CcSEcCtD
Prazosin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000699	0.0061	CcSEcCtD
Prazosin—Diarrhoea—Teniposide—lymphatic system cancer	0.000689	0.006	CcSEcCtD
Prazosin—Alopecia—Vincristine—lymphatic system cancer	0.000672	0.00586	CcSEcCtD
Prazosin—Discomfort—Bleomycin—lymphatic system cancer	0.000669	0.00583	CcSEcCtD
Prazosin—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000658	0.00573	CcSEcCtD
Prazosin—Alopecia—Mitoxantrone—lymphatic system cancer	0.000655	0.00571	CcSEcCtD
Prazosin—Vision blurred—Carmustine—lymphatic system cancer	0.000654	0.0057	CcSEcCtD
Prazosin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000652	0.00568	CcSEcCtD
Prazosin—Oedema—Bleomycin—lymphatic system cancer	0.000649	0.00565	CcSEcCtD
Prazosin—Vomiting—Teniposide—lymphatic system cancer	0.00064	0.00558	CcSEcCtD
Prazosin—Asthenia—Fludarabine—lymphatic system cancer	0.000635	0.00553	CcSEcCtD
Prazosin—Rash—Teniposide—lymphatic system cancer	0.000635	0.00553	CcSEcCtD
Prazosin—Dermatitis—Teniposide—lymphatic system cancer	0.000634	0.00553	CcSEcCtD
Prazosin—Headache—Teniposide—lymphatic system cancer	0.000631	0.0055	CcSEcCtD
Prazosin—Pruritus—Fludarabine—lymphatic system cancer	0.000626	0.00546	CcSEcCtD
Prazosin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000608	0.0053	CcSEcCtD
Prazosin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000605	0.00528	CcSEcCtD
Prazosin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000598	0.00522	CcSEcCtD
Prazosin—Nausea—Teniposide—lymphatic system cancer	0.000598	0.00521	CcSEcCtD
Prazosin—Vertigo—Vincristine—lymphatic system cancer	0.000595	0.00519	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000591	0.00515	CcSEcCtD
Prazosin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000582	0.00508	CcSEcCtD
Prazosin—Malaise—Mitoxantrone—lymphatic system cancer	0.000582	0.00507	CcSEcCtD
Prazosin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000578	0.00504	CcSEcCtD
Prazosin—Oedema—Carmustine—lymphatic system cancer	0.000566	0.00493	CcSEcCtD
Prazosin—Vomiting—Fludarabine—lymphatic system cancer	0.000562	0.0049	CcSEcCtD
Prazosin—Rash—Fludarabine—lymphatic system cancer	0.000558	0.00486	CcSEcCtD
Prazosin—Dermatitis—Fludarabine—lymphatic system cancer	0.000557	0.00486	CcSEcCtD
Prazosin—Pain—Bleomycin—lymphatic system cancer	0.000555	0.00483	CcSEcCtD
Prazosin—Headache—Fludarabine—lymphatic system cancer	0.000554	0.00483	CcSEcCtD
Prazosin—Tachycardia—Carmustine—lymphatic system cancer	0.000553	0.00482	CcSEcCtD
Prazosin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000549	0.00479	CcSEcCtD
Prazosin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000542	0.00473	CcSEcCtD
Prazosin—Oedema—Vincristine—lymphatic system cancer	0.00054	0.00471	CcSEcCtD
Prazosin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000535	0.00466	CcSEcCtD
Prazosin—Oedema—Mitoxantrone—lymphatic system cancer	0.000526	0.00459	CcSEcCtD
Prazosin—Nausea—Fludarabine—lymphatic system cancer	0.000525	0.00458	CcSEcCtD
Prazosin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000522	0.00455	CcSEcCtD
Prazosin—Shock—Mitoxantrone—lymphatic system cancer	0.000518	0.00451	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000516	0.0045	CcSEcCtD
Prazosin—Urticaria—Bleomycin—lymphatic system cancer	0.000515	0.00449	CcSEcCtD
Prazosin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000514	0.00448	CcSEcCtD
Prazosin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000513	0.00447	CcSEcCtD
Prazosin—Insomnia—Carmustine—lymphatic system cancer	0.000512	0.00446	CcSEcCtD
Prazosin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000509	0.00444	CcSEcCtD
Prazosin—Paraesthesia—Carmustine—lymphatic system cancer	0.000508	0.00443	CcSEcCtD
Prazosin—Dyspnoea—Carmustine—lymphatic system cancer	0.000505	0.0044	CcSEcCtD
Prazosin—Somnolence—Carmustine—lymphatic system cancer	0.000503	0.00439	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000492	0.00429	CcSEcCtD
Prazosin—Insomnia—Vincristine—lymphatic system cancer	0.000489	0.00426	CcSEcCtD
Prazosin—Paraesthesia—Vincristine—lymphatic system cancer	0.000485	0.00423	CcSEcCtD
Prazosin—Pain—Carmustine—lymphatic system cancer	0.000484	0.00422	CcSEcCtD
Prazosin—Constipation—Carmustine—lymphatic system cancer	0.000484	0.00422	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00048	0.00418	CcSEcCtD
Prazosin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000478	0.00417	CcSEcCtD
Prazosin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000473	0.00412	CcSEcCtD
Prazosin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000469	0.00409	CcSEcCtD
Prazosin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000468	0.00408	CcSEcCtD
Prazosin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000467	0.00407	CcSEcCtD
Prazosin—Fatigue—Vincristine—lymphatic system cancer	0.000466	0.00406	CcSEcCtD
Prazosin—Asthenia—Bleomycin—lymphatic system cancer	0.000465	0.00406	CcSEcCtD
Prazosin—Pain—Vincristine—lymphatic system cancer	0.000462	0.00403	CcSEcCtD
Prazosin—Constipation—Vincristine—lymphatic system cancer	0.000462	0.00403	CcSEcCtD
Prazosin—Pruritus—Bleomycin—lymphatic system cancer	0.000459	0.004	CcSEcCtD
Prazosin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000454	0.00396	CcSEcCtD
Prazosin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000452	0.00394	CcSEcCtD
Prazosin—Pain—Mitoxantrone—lymphatic system cancer	0.00045	0.00392	CcSEcCtD
Prazosin—Constipation—Mitoxantrone—lymphatic system cancer	0.00045	0.00392	CcSEcCtD
Prazosin—Body temperature increased—Carmustine—lymphatic system cancer	0.000448	0.0039	CcSEcCtD
Prazosin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000442	0.00385	CcSEcCtD
Prazosin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000434	0.00378	CcSEcCtD
Prazosin—Body temperature increased—Vincristine—lymphatic system cancer	0.000427	0.00372	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000425	0.0037	CcSEcCtD
Prazosin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000418	0.00364	CcSEcCtD
Prazosin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000417	0.00364	CcSEcCtD
Prazosin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000416	0.00363	CcSEcCtD
Prazosin—Vomiting—Bleomycin—lymphatic system cancer	0.000412	0.00359	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—lymphatic system cancer	0.000411	0.00358	CcSEcCtD
Prazosin—Rash—Bleomycin—lymphatic system cancer	0.000409	0.00356	CcSEcCtD
Prazosin—Dermatitis—Bleomycin—lymphatic system cancer	0.000409	0.00356	CcSEcCtD
Prazosin—Asthenia—Carmustine—lymphatic system cancer	0.000406	0.00354	CcSEcCtD
Prazosin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000398	0.00347	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—lymphatic system cancer	0.000388	0.00338	CcSEcCtD
Prazosin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000388	0.00338	CcSEcCtD
Prazosin—Asthenia—Vincristine—lymphatic system cancer	0.000388	0.00338	CcSEcCtD
Prazosin—Diarrhoea—Carmustine—lymphatic system cancer	0.000387	0.00338	CcSEcCtD
Prazosin—Nausea—Bleomycin—lymphatic system cancer	0.000385	0.00336	CcSEcCtD
Prazosin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000378	0.00329	CcSEcCtD
Prazosin—Dizziness—Carmustine—lymphatic system cancer	0.000374	0.00326	CcSEcCtD
Prazosin—Diarrhoea—Vincristine—lymphatic system cancer	0.00037	0.00322	CcSEcCtD
Prazosin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00036	0.00314	CcSEcCtD
Prazosin—Vomiting—Carmustine—lymphatic system cancer	0.00036	0.00314	CcSEcCtD
Prazosin—Dizziness—Vincristine—lymphatic system cancer	0.000357	0.00312	CcSEcCtD
Prazosin—Rash—Carmustine—lymphatic system cancer	0.000357	0.00311	CcSEcCtD
Prazosin—Dermatitis—Carmustine—lymphatic system cancer	0.000357	0.00311	CcSEcCtD
Prazosin—Headache—Carmustine—lymphatic system cancer	0.000355	0.00309	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—lymphatic system cancer	0.000344	0.003	CcSEcCtD
Prazosin—Vomiting—Vincristine—lymphatic system cancer	0.000344	0.003	CcSEcCtD
Prazosin—Rash—Vincristine—lymphatic system cancer	0.000341	0.00297	CcSEcCtD
Prazosin—Dermatitis—Vincristine—lymphatic system cancer	0.00034	0.00297	CcSEcCtD
Prazosin—Headache—Vincristine—lymphatic system cancer	0.000339	0.00295	CcSEcCtD
Prazosin—Nausea—Carmustine—lymphatic system cancer	0.000336	0.00293	CcSEcCtD
Prazosin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000335	0.00292	CcSEcCtD
Prazosin—Rash—Mitoxantrone—lymphatic system cancer	0.000332	0.00289	CcSEcCtD
Prazosin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000332	0.00289	CcSEcCtD
Prazosin—Headache—Mitoxantrone—lymphatic system cancer	0.00033	0.00287	CcSEcCtD
Prazosin—Alopecia—Methotrexate—lymphatic system cancer	0.000326	0.00284	CcSEcCtD
Prazosin—Nausea—Vincristine—lymphatic system cancer	0.000321	0.0028	CcSEcCtD
Prazosin—Nausea—Mitoxantrone—lymphatic system cancer	0.000313	0.00273	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—lymphatic system cancer	0.000303	0.00264	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000298	0.0026	CcSEcCtD
Prazosin—Malaise—Methotrexate—lymphatic system cancer	0.00029	0.00253	CcSEcCtD
Prazosin—Vertigo—Methotrexate—lymphatic system cancer	0.000289	0.00252	CcSEcCtD
Prazosin—Arthralgia—Methotrexate—lymphatic system cancer	0.000274	0.00238	CcSEcCtD
Prazosin—Discomfort—Methotrexate—lymphatic system cancer	0.00027	0.00236	CcSEcCtD
Prazosin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000254	0.00221	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000239	0.00208	CcSEcCtD
Prazosin—Insomnia—Methotrexate—lymphatic system cancer	0.000237	0.00207	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000235	0.00205	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000234	0.00204	CcSEcCtD
Prazosin—Somnolence—Methotrexate—lymphatic system cancer	0.000233	0.00203	CcSEcCtD
Prazosin—Fatigue—Methotrexate—lymphatic system cancer	0.000226	0.00197	CcSEcCtD
Prazosin—Pain—Methotrexate—lymphatic system cancer	0.000224	0.00195	CcSEcCtD
Prazosin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000216	0.00188	CcSEcCtD
Prazosin—Urticaria—Methotrexate—lymphatic system cancer	0.000208	0.00182	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000207	0.00181	CcSEcCtD
Prazosin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000193	0.00168	CcSEcCtD
Prazosin—Asthenia—Methotrexate—lymphatic system cancer	0.000188	0.00164	CcSEcCtD
Prazosin—Pruritus—Methotrexate—lymphatic system cancer	0.000186	0.00162	CcSEcCtD
Prazosin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000179	0.00156	CcSEcCtD
Prazosin—Dizziness—Methotrexate—lymphatic system cancer	0.000173	0.00151	CcSEcCtD
Prazosin—Vomiting—Methotrexate—lymphatic system cancer	0.000167	0.00145	CcSEcCtD
Prazosin—Rash—Methotrexate—lymphatic system cancer	0.000165	0.00144	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—lymphatic system cancer	0.000165	0.00144	CcSEcCtD
Prazosin—Headache—Methotrexate—lymphatic system cancer	0.000164	0.00143	CcSEcCtD
Prazosin—Nausea—Methotrexate—lymphatic system cancer	0.000156	0.00136	CcSEcCtD
